Master generic substitution and biosimilars with targeted continuing education. Learn how to navigate FDA Orange Book updates, bioequivalence rules, and state-specific CE requirements to ensure patient safety.
READ MORE
Biosimilars are highly similar versions of complex biologic drugs that offer the same safety and effectiveness at a lower cost. Unlike generics, they're not exact copies but are rigorously tested by the FDA to ensure they work the same way. Learn how they help patients access vital treatments.
READ MORE